Dr. Brooke Olberding is a Milledgeville, Illinois based female chiropractor who is specialized as General Chiropractor. Active license number of Dr. Brooke Olberding as General Chiropractor is 038.013736 in Illinois. Dr. Brooke Olberding is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Brooke Olberding speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
DC
Gender:
Female
Practice Address:
444 N Main Ave, Milledgeville, Illinois, 61051-9506
Phone:
815-855-3061
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1871165639
NPI Enumeration Date:
12 Jul, 2021
NPI Last Update On:
12 Jul, 2021
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Brooke Olberding are as mentioned below.
License Number
Specialization
State
Status
038.013736
Chiropractor
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 132, Milledgeville, Illinois
Zip:
61051-0132
Phone Number:
815-855-3061
Fax Number:
--
Patients can reach Dr. Brooke Olberding at 444 N Main Ave, Milledgeville, Illinois or can call to book an appointment on 815-855-3061. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.